More Than Just Dander
First, a sort of meta-comment in the form of a shout-out to HCRenewal's intrepid editor, Dr. Roy Poses, for his just-published analysis of what we might call " blogging: rise and fall. " He sees decline reflected in publications long devoted to health and health policy, yet now flaking off.Methinks, however, despite the usefulness of his overview of recent decades, Dr. P need not fret excessively. Water spilling out of the barrel's lip will slow down once folks come along and punch a whole bunch of little mid-section tweet-holes in it. Information still flows. (Sort of.) In any case, surely there's overlap between blogs'and tweets'readerships. Surely well-researched and -reasoned long form still has its place. Unfortunately, hard to know for sure: it's hard to measure. Nobody's polling these folks and to my knowledge information scientists haven't published much--a quick search inside Google Scholar bears this out--that's of a quantitative nature.So we're left with admittedly rather unsatisfactory anecdotal reports on people who need blogs like ours and find their way to it. Congressional staffers you know who you are. Rightly or wrongly, I'm hopeful. Maybe we shade this a little by the suspicion that many younger social media users share with me a short attention span. Hence they come to rely more and more on quick hits. In any case, let's hope this is evolution and diversification, not just entropy and a race to the bottom.Now to my theme of the day. Y...
CONCLUSIONS: The practice of self-medication with analgesics is frequent among patients with chronic pain, which may be due to the underprescription of more potent analgesics, such as opioids. It can also be said that, given the data presented, there is no crisis of recreational opioid use in the studied population. PMID: 31703816 [PubMed - as supplied by publisher]
In Getting Wrecked: Women, Incarceration, and the American Opioid Crisis, a Rikers Island doctor says drug treatment in U.S. jails and prisons is often shaped by societal prejudice, not science.(Image credit: Catie Dull/NPR)
AbstractIntroductionOral semaglutide is the first orally administered glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes, and has been evaluated in the PIONEER clinical trial program. These trials assessed the proportions of patients achieving single and composite endpoints, encompassing glycemic control [defined in terms of glycated hemoglobin (HbA1c)], weight loss, and hypoglycemia. The present study assessed the cost of control with oral semaglutide versus empagliflozin, sitagliptin, and liraglutide in the US.MethodsFour endpoints were evaluated: (1) HbA1c ≤ 6.5%; (2) HbA1c
Publication date: Available online 10 November 2019Source: Seminars in Cancer BiologyAuthor(s): Jessica Burns, Christopher P Wilding, Robin L Jones, Paul H HuangAbstractSarcomas are a rare group of mesenchymal cancers comprising over 70 different histological subtypes. For the majority of these diseases, the molecular understanding of the basis of their initiation and progression remains unclear. As such, limited clinical progress in prognosis or therapeutic regimens have been made over the past few decades. Proteomics techniques are being increasingly utilised in the field of sarcoma research. Proteomic research efforts h...
More News: Addiction | Agency for Healthcare Research and Quality (AHRQ) | American Health | Anesthesia | Anesthesiology | Babies | Blindness | Blogging | Burns | Economic Slowdown | Education | Environmental Health | Eyes | Government | Headache | Health Management | Hospitals | Hydrocodone | Hypermetropia (long sighted) | Insurance | Internal Medicine | Internet | Learning | Legislation | Lortab | Medical Ethics | Migraine | Opthalmology | Oxycodone | OxyContin | Percocet | Pharmaceuticals | Poisoning | Politics | Science | Smokers | Study | Switzerland Health | Trump | Universities & Medical Training | USA Health | Vicodin